Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|8|4|238-243
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.8, Iss.4, 2008-12, pp. : 238-243
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lipid-Lowering Treatment in Coronary Artery Disease: How Low Should Cholesterol Go?
By Jones P.H.
Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. :
Access to resources
Recommend
Lowering of LDL-cholesterol may increase risk of cancer
Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. :
Lowering LDL Cholesterol: Where Is the End of the Journey?
Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. :
More aggressive targeting of LDL-cholesterol warranted
Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. :